The Current Ratio as of November 2024 (TTM) for Kala Pharmaceuticals, Inc. (KALA) is 3.07

According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.07. This represents a change of -36.24% compared to the average of 4.81 of the last 4 quarters.

Kala Pharmaceuticals, Inc. (KALA) Historical Current Ratio (quarterly & annually)

How has KALA Current Ratio performed in the past?

The mean historical Current Ratio of Kala Pharmaceuticals, Inc. over the last ten years is 5.88. The current 3.07 Current Ratio has changed 5.11% with respect to the historical average. Over the past ten years (40 quarters), KALA's Current Ratio was at its highest in in the March 2018 quarter at 20.40. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Kala Pharmaceuticals, Inc. (KALA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kala Pharmaceuticals, Inc. (KALA) Average Current Ratio

How has KALA Current Ratio performed in the past?

The current Current Ratio of Kala Pharmaceuticals, Inc. (KALA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kala Pharmaceuticals, Inc. (KALA) Current Ratio vs. Peers

How is KALA’s Current Ratio compared to its peers?

Kala Pharmaceuticals, Inc.’s Current Ratio is greater than Mallinckrodt plc (0.57), greater than Lifecore Biomedical, Inc. (1.83), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79), greater than Adamis Pharmaceuticals Corporation (0.58), greater than Shuttle Pharmaceuticals Holdings, Inc. (1.79), greater than Journey Medical Corporation (1.36), greater than Akanda Corp. (1.41), greater than Organogenesis Holdings Inc. (2.73), greater than Biofrontera Inc. (1.89), less than Guardion Health Sciences, Inc. (16.67), greater than China Pharma Holdings, Inc. (0.84), less than Alkermes plc (3.45), less than Neurocrine Biosciences, Inc. (4.37), less than Intra-Cellular Therapies, Inc. (7.66), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Dynavax Technologies Corporation (14.18),

Build a custom stock screener for Kala Pharmaceuticals, Inc. (KALA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kala Pharmaceuticals, Inc. (KALA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.